FDA Brief

Warning letters Food

FDA warning letter to

Dalian Lingfa Food Co., Ltd.

High riskIssued Jun 3, 2024Posted Jul 16, 2024Center for Food Safety and Applied Nutrition (CFSAN)

Dalian Lingfa Food did not control Clostridium botulinum risk in vacuum-packed ready-to-eat bamboo shoots, FDA says.

What happened

FDA inspected the company's food plant in Dalian, China on January 17-19, 2024 and issued a Form FDA 483 (the list of observations written at the end of an inspection). Investigators found the hazard analysis for seasoned bamboo shoots did not consider Clostridium botulinum growth and toxin formation in vacuum packaging, that bags of U.S.-bound product sat in an unrefrigerated staging room with no thermometer for 1 to 6 days, and that refrigerated warehouse temperatures went above the level at which that bacteria can grow in May, June, July, August and October 2023. FDA calls the products adulterated (a legal term meaning they may be injurious to health because of how they were prepared, packed or held), and says the company's February 2024 responses did not include a revised hazard analysis.

What FDA found

  1. The hazard analysis did not identify Clostridium botulinum growth and toxin formation from vacuum (reduced oxygen) packaging as a hazard needing a preventive control during processing and finished product storage.

    21 CFR 117.130(a)(1)
  2. Bags of U.S.-bound seasoned bamboo shoots were held in an unrefrigerated staging room without a thermometer, and production records from November and December 2023 showed 1 to 6 days of storage there with no temperature monitoring.

    21 CFR 117.135(c)(1)
  3. The products get no treatment lethal to C. botulinum before or after packaging and the formulation does not prevent its outgrowth or toxin formation.

    21 CFR 117.135(c)(1)
  4. Refrigerated warehouse records showed temperatures above the level at which C. botulinum can grow and form toxin on many occasions in May, June, July, August and October 2023.

    21 CFR 117.135(c)(1)
  5. Temperature was recorded only once when product entered storage and once when it left, so the records do not show control of C. botulinum for the whole storage period.

    21 CFR 117.165
  6. The company has not established corrective action procedures for when its temperature preventive controls are not properly carried out; FDA also commented that the cooling step is not identified as a hazard needing a preventive control.

    21 CFR 117.150(a)(1)

What FDA wants

FDA tells the company to respond in writing within 15 working days describing the specific steps taken to correct the violation, prevent it from recurring, and copies of related records. If corrections cannot be finished in that time, the company must explain the delay and say when they will be done.

Who should pay attention

  • U.S. importers and distributors of vacuum-packed ready-to-eat vegetable products from China
  • brands sourcing refrigerated ready-to-eat foods from contract processors
  • retailers and food service buyers of TETSUJIN-brand bamboo shoots

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. CNC Noodle Corporation

    FDA warned CNC Noodle Corporation that its Hayward, California noodle plant had insanitary conditions, no pathogen or allergen controls, and mislabeled products.

    High risk
  2. ABC Food Corp

    ABC Food Corp's ready-to-eat rice noodles and tofu were made without required hazard analysis and preventive controls.

    High risk
  3. Rama Food Manufacture Corp.

    FDA warns Rama Food Manufacture after inspections found insanitary conditions and preventive-control failures at its California ready-to-eat rice noodle plants.

    High risk
  4. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk